Cardiomiopatia Hipertrófica Online (Hypertrophic cardiomyopathy)

■ Cardiopulmonary exercise test in hypertrophic cardiomyopathy

D Magri, C Santolamazza

Annals of American Thoracic Society 2017, vol 14 (Supplement _1)

http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201611-884FR

■ Hypertrophic cardiomyopathy in children

A Arghami, J A Dearani, S M Said et al

Annals of Cardiothoracic Surgery july 2017, vol 6 (4)

http://www.annalscts.com/article/view/15787/html

■ Surgical treatment for hypertrophic cardiomyopathy: a historical perspective

D Hang, A Nguyen, H V Schaff

Annals of Cardiothoracic Surgery 2017, vol 6 (4)

http://www.annalscts.com/article/view/14525/html

■ Outcome of alcohol septal ablation in midly symptomatic patients with hypertrophic obstructive cardiomyopathy: a long-term follow-up study based on the Euro-Alcohol Septal Ablation Registry

Josef Veselka, Lothar Faber, Max Liebregts et al

J Am Heart Assoc. 2017 May; 6(5): e005735.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524107/

■ A one health approach to hypertrophic cardiomyopathy

Yu Ueda, Joshua A. Stern

Yale J Biol Med. 2017 Sep; 90(3): 433–448

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612186/

■ Speckle tracking echocardiography to assess regional ventricular function in patients with apical hypertrophic cardiomyopathy

M C Saccheri, T FCianciulli, L A Morita et al

World J Cardiol. 2017 Apr 26; 9(4): 363–370

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411971/

■ Atrial fibrillation and anticoagulation in hypertrophic cardiomyopathy

C Fielder Camm, A John Camm

Arrhythm Electrophysiol Rev. 2017 Jun; 6(2): 63–68

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522714/

■ Hypertrophic cardiomyopathy and coronary fistulae

D F Waterhouse, T M Murphy, C McCreery, R O´Hanlon

Br J Cardiol 2017, vol 24: 118-119

https://bjcardio.co.uk/2017/07/hypertrophic-cardiomyopathy-and-coronary-fistulae/

■ Implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: an update systematic review and meta-analysis of outcomes and complications

Nelson Wang, Ashleigh Xie, Richard Tjahjono et al

Ann Cardiothorac Surg. 2017 Jul; 6(4): 298–306.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602202/

■ The role of cardiac MRI in the diagnosis and risk stratification of hypertrophic cardiomyopathy

Ethan J Rowin, Martin S Maron

Arrhythm Electrophysiol Rev. 2016 Dec; 5(3): 197–202

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248669/

■ Obstructive forms of hypertrophic cardiomyopathy-left ventricular outflow tract gradient: novel methods of provocation, monitoring of biomarkers, and recent advances in the treatment

P P Dimitrov, R Rajtar-Salwa

BioMed Research International 2016 (2016, Article ID 1575130, 8 pages

https://www.hindawi.com/journals/bmri/2016/1575130/

■ Midventricular hypertrophic cardiomyopathy with apical aneurysm: potential for underdiagnosis and value of multimodality imaging

A Sivanandam, K Ananthasubramaniam

Case Reports in Cardiology 2016 (2016), Article ID 9717948, 5 pages

https://www.hindawi.com/journals/cric/2016/9717948/

■ Drug therapy for hypertrophic cardiomyopathy: physiology and practice

Mark V. Sherrid

Curr Cardiol Rev. 2016 Feb; 12(1): 52–65

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807719/

■ Miocardiopatía dilatada reversible asociada a hipotiroidismo severo.

Pérez Baztarrica, Gabriel et al.

Rev Chil Cardiol, 2017, vol.36, no.2, p.132-13

http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-85602017000200007&lng=en&nrm=iso

■ Hypertrophic cardiomyopathy in a monozygotic twin

Attila Kovács, Andrea Ágnes Molnár, Csilla Celeng et al

Circulation: Cardiovascular Imaging. 2016;9:e00479

http://circimaging.ahajournals.org/content/9/6/e004794

■ Histologic sequelae of apical hypertrophic cardiomyopathy: dystrophic calcification

S G Saba, J N Makarys, N Rahmani, R Jadonath

Clin Med Insights Cardiol 2017, vol 11: 1179546817710934

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457028/

■ Cardiac Catheterization in a Patient with Obstructive Hypertrophic Cardiomyopathy and Syncope

Nunes, Rafael Amorim Belo et al

Arq. Bras. Cardiol., Sept 2017, vol.109, no.3, p.270-270

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2017000900270&lng=pt&nrm=iso

■ Mutação em Hetrozigose Composta no Gene da Proteína C Ligante de Miosina e sua Expressão Fenotípica na Cardiomiopatia Hipertrófica

Rafael, Julianny Freitas et al.

Arq. Bras. Cardiol., Apr 2017, vol.108, no.4, p.354-360

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2017000400354&lng=pt&nrm=iso&tlng=pt

■ Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy

Irene Mademont-Soler, Jesus Mates, Raquel Yotti et AL

PLoS One. 2017; 12(8): e0181465

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542623/

■ Morte súbita na cardiomiopatia hipertrófica

M I Bittencourt, S A Cader, D V Araújo et al

International Journal of Cardiovascular Sciences 2016, vol 29 (6): 504-511

http://www.onlineijcs.org/sumario/29/pdf/v29n6a11.pdf

■ Ressonância Magnética e Tomografia Computadorizada Cardíaca na Cardiomiopatia Hipertrófica: Atualidades

Oliveira, Diogo Costa Leandro de et AL

Arq. Bras. Cardiol., Aug 2016, vol.107, no.2, p.163-172

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016004100163&lng=pt&nrm=iso&tlng=pt

■ Obstructive form of hypertrophic cardiomyopathy-left ventricular outflow tract gradient: novel methods of provocation, monitoring of biomarkers, and recent advances in the treatment

Pawel Petkow Dimitrow, Renata Rajtar-Salwa

Biomed Res Int. 2016; 2016: 1575130

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877458/

■ Reprodutibilidade de Padrões de Realce pelo Gadolínio e Espessura Parietal em Cardiomiopatia Hipertrófica

Rodriguez-Granillo, Gaston A. et AL

Arq. Bras. Cardiol., July 2016, vol.107, no.1, p.48-54.

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016004000048&lng=pt&nrm=iso&tlng=pt

■ Hypertrophic cardiomyopathy: a review

N Hensley, J Dietrich, D Nyhan et al

Anesthesia & Analgesia 2015, vol 120 (3): p554-546

http://journals.lww.com/anesthesia-analgesia/Fulltext/2015/03000/Hypertrophic_Cardiomyopathy___A_Review.13.aspx

■ Hypertrophic cardiomyopathy: a review

B A Houston, G R Stevens

Clin Med Insights Cardiol 2014, vol I (Suppl 1): 53-65

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309724/

■ Hypertrophic cardiomyopathy, athlete´s heart, or both – a case of hypertrophic cardiomyopathy regression

Kalie Y. Kebed, J. Martijn Bos, Nandan S. Anavekar et al

Circulation: Cardiovascular Imaging. 2015;8:e003312

http://circimaging.ahajournals.org/content/8/7/e003312

■ Clinical profile of athletes with hypertrophic cardiomyopathy

N Sheikh, M Papadakis, F Schnell et al

Circulation: Cardiovascular Imaging 2015, vol 8: e003454

http://circimaging.ahajournals.org/content/8/7/e003454

■ Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients without severe septal hypertrophy implications of mitral valve and papillary muscle abnormatilities

P Patel, A Dhillon, Z B Popovic et al

Circulation: Cardiovascular Imaging 2015, vol 8: e003132

http://circimaging.ahajournals.org/content/8/7/e003132

■ Cardiomiopatia hipertrófica apical

M M de Castro, A Fuchs, M C da Rocha et al

Revista Brasileira de Cardiologia 2014, vol 27 (1)

http://www.rbconline.org.br/artigo/cardiomiopatia-hipertrofica-apical/

■ Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy

Catarina Roma-Rodrigues, Alexandra R Fernandes

Appl Clin Genet. 2014; 7: 195–208

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199654/

■ Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?

Li Zhang, Obinna Mmagu, Liwen Liu et al

World J Cardiol. 2014 Aug 26; 6(8): 764–770.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163705/

■ Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment

J L Jacoby, E C DePasquale, W J McKenna

CMAJ 2013, vol 185 (2): 127-134

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563885/

■ Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population

Konstantinos C. Siontis, Jeffrey B. Geske, Kevin Ong, Rick A. Nishimura, Steve R. Ommen, Bernard J. Gersh

J Am Heart Assoc. 2014 Jun; 3(3): e001002

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309084/

■ Hypertrophic cardiomyopathy in 2013: current speculations and future perspectives

Georgios K Efthimiadis, Efstathios D Pagourelias, Thomas Gossios, Thomas Zegkos

World J Cardiol. 2014 Feb 26; 6(2): 26–37

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935059/

■ Risk stratification at the time of diagnosis for children with hypertrophic cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry Study Group

Steven E Lipshultz, E John Orav, James D Wilkinson et al

for the Pediatric Cardiomyopathy Registry Study Group

Lancet. 2013 Dec 7; 382(9908): 1889–1897

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007309/

■ Variações eletrocardiográficas em paciente portador de cardiomiopatia hipertrófica em uso de CDI

M E T Pfeiffer, D C Abreu, L Stewart et al

Revista Brasileira de Cardiologia 2013, vol 26 (2)

http://www.rbconline.org.br/artigo/variacoes-eletrocardiograficas-em-paciente-portador-de-cardiomiopatia-hipertrofica-em-uso-de-cdi/

■ Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

Martin S Maron

J Cardiovasc Magn Reson. 2012; 14(1): 13

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293092/